• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Spain Kevin disposed of 2,604,023 shares and converted options into 2,410,273 shares (SEC Form 4)

    2/14/25 4:05:06 PM ET
    $DOCS
    EDP Services
    Technology
    Get the next $DOCS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Spain Kevin

    (Last) (First) (Middle)
    C/O EMERGENCE CAPITAL
    5 PIER, STE. 102

    (Street)
    SAN FRANCISCO CA 94111

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Doximity, Inc. [ DOCS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    02/12/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 02/12/2025 C(1) 2,410,273 A $0(1) 2,410,273 I By Emergence Capital Partners II, L.P.(2)
    Class A Common Stock 02/12/2025 J(1) 2,410,273 D $0(1) 0 I By Emergence Capital Partners II, L.P.(2)
    Class A Common Stock 02/12/2025 J(3) 193,750 D $0(3) 387,500 I By Emergence Capital Opportunity I, L.P.(4)
    Class A Common Stock 6,360(5) D
    Class A Common Stock 363,083(6) I See footnote(6)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class B Common Stock (7) 02/12/2025 C(1) 2,410,273 (7) (7) Class A Common Stock 2,410,273 $0 2,410,273 I By Emergence Capital Partners II, L.P.(2)
    Explanation of Responses:
    1. On February 12, 2025, Emergence Capital Partners II, L.P. ("ECP II") converted in the aggregate 2,410,273 shares of the Issuer's Class B Common Stock into 2,410,273 shares of the Issuer's Class A Common Stock. Subsequently on the same date, ECP II distributed in-kind, without consideration, all 2,410,273 shares of Class A Common Stock pro-rata to its partners, including its limited partners and its general partner, Emergence Equity Partners II, L.P. ("EEP II"), in accordance with the exemptions under Rule 16a-9 and Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Upon receipt by EEP II of its pro rata interest of the distribution (507,135 shares of Class A Common Stock), EEP II distributed in-kind, without consideration, all such shares pro-rata to its limited partners in accordance with the exemptions under Rule 16a-9 and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
    2. These shares are held directly by ECP II. The sole general partner of ECP II is EEP II, and the sole general partner of EEP II is Emergence GP Partners, LLC ("EGP"). The Reporting Person is a member of EEP II. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by ECP II, except to the extent, if any, of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 or any other purpose.
    3. On February 12, 2025, Emergence Capital Opportunity I, L.P. ("ECO I") distributed in-kind, without consideration, 193,750 shares of Class A Common Stock pro-rata to its limited partners in accordance with the exemptions under Rule 16a-9 and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
    4. These shares are held directly by ECO I. The sole general partner of ECO I is Emergence Equity Partners VI, L.P. ("EEP VI"), and the sole general partner of EEP VI is EGP. The Reporting Person is a member of EEP VI. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by ECO I, except to the extent, if any, of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 or any other purpose.
    5. Represents 6,360 restricted stock units ("RSUs"). The Reporting Person, a member of EEP II, is contractually obligated to transfer and/or remit the proceeds of any sale of shares issued upon vesting of RSUs to EEP II. As such, the Reporting Person disclaims Section 16 beneficial ownership of such shares, except to the extent, if any, of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 or any other purpose.
    6. Includes 59,692 shares received pursuant to the distribution-in-kind, as described in footnote (1) and also includes shares received in prior distributions-in-kind, and are held by The Spain-Goralnik Family Trust 12/7/12. The Reporting Person disclaims Section 16 beneficial ownership of such shares, except to the extent, if any, of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 or any other purpose.
    7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder, and has no expiration. Each share of Class B Common Stock will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the holder; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.
    /s/ Julie Bell, by Power of Attorney from Kevin Spain 02/14/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DOCS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOCS

    DatePrice TargetRatingAnalyst
    2/7/2025$31.00 → $78.00Neutral → Overweight
    Piper Sandler
    2/7/2025$60.00 → $90.00Market Perform → Outperform
    Leerink Partners
    12/20/2024$55.00Equal-Weight
    Stephens
    12/4/2024$55.00Neutral
    Mizuho
    11/15/2024$58.00Neutral
    Goldman
    11/14/2024$33.00 → $53.00Underweight → Equal-Weight
    Morgan Stanley
    11/13/2024$40.00 → $60.00Buy → Hold
    Canaccord Genuity
    11/8/2024$19.00 → $41.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025, at 10:25 a.m. Eastern Time/7:25 a.m. Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and rese

      2/13/25 4:29:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

      Earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the Video Conferencing Platforms segment. This is the fourth consecutive year that Doximity has earned the top position. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including operations, product, relationship, value, culture, and loyalty. These ratings, which are based on live interviews with over 80 health system leaders and their staff, reinforce Doximity's leadership in delivering a reliable, easy-to-use virtual care platform. "We're hono

      2/6/25 4:02:00 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Wampler Kira Scherer converted options into 2,000 shares and sold $113,853 worth of shares (2,000 units at $56.93) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:42 PM ET
      $DOCS
      EDP Services
      Technology
    • Chief Financial Officer Bryson Anna converted options into 95,000 shares and sold $5,575,235 worth of shares (95,000 units at $58.69) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:07 PM ET
      $DOCS
      EDP Services
      Technology
    • Chief Financial Officer Bryson Anna converted options into 32,900 shares, increasing direct ownership by 10% to 357,165 units (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      4/22/25 4:14:03 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    SEC Filings

    See more
    • SEC Form 144 filed by Doximity Inc.

      144 - Doximity, Inc. (0001516513) (Subject)

      5/2/25 4:06:18 PM ET
      $DOCS
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

      SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

      3/7/25 10:01:30 AM ET
      $DOCS
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

      SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

      2/13/25 4:01:03 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Financials

    Live finance-specific insights

    See more
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity Announces Fiscal 2025 Third Quarter Financial Results

      Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers." Fiscal 2025 Third Quarter Financial Highlights All com

      2/6/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

      1/16/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Doximity upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Doximity from Neutral to Overweight and set a new price target of $78.00 from $31.00 previously

      2/7/25 9:03:46 AM ET
      $DOCS
      EDP Services
      Technology
    • Doximity upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Doximity from Market Perform to Outperform and set a new price target of $90.00 from $60.00 previously

      2/7/25 6:59:36 AM ET
      $DOCS
      EDP Services
      Technology
    • Stephens initiated coverage on Doximity with a new price target

      Stephens initiated coverage of Doximity with a rating of Equal-Weight and set a new price target of $55.00

      12/20/24 7:32:05 AM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Doximity Inc.

      SC 13G/A - Doximity, Inc. (0001516513) (Subject)

      11/14/24 5:22:01 PM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Doximity Inc.

      SC 13G - Doximity, Inc. (0001516513) (Subject)

      11/14/24 11:42:53 AM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Doximity Inc.

      SC 13G - Doximity, Inc. (0001516513) (Subject)

      11/12/24 9:55:17 AM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Leadership Updates

    Live Leadership Updates

    See more
    • Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

      With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

      9/26/24 6:05:00 AM ET
      $DOCS
      $RELY
      $LVGO
      EDP Services
      Technology
      Business Services
      Consumer Discretionary
    • Doximity Appoints Phoebe Yang to Its Board of Directors

      Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

      8/4/22 4:02:00 PM ET
      $DOCS
      EDP Services
      Technology